Wolf-Dieter Vigelius

Title: Wolf-Dieter Vigelius: Innovator in Aminosulfonic Acid Derivatives

Introduction

Wolf-Dieter Vigelius is a notable inventor based in Denzlingen, Germany. He has made significant contributions to the field of chemistry, particularly in the development of new aminosulfonic acid derivatives. With a total of 5 patents to his name, Vigelius has demonstrated a commitment to advancing medical therapies.

Latest Patents

Among his latest patents, Vigelius has developed cycloaliphatic aminosulfonic acid derivatives. These new aminosulfonic acids, characterized by their general formula, exhibit excellent tolerance and valuable cardiovascular properties. They serve as a promising therapy for dysrhythmia and are considered superior to procaine. Additionally, he has worked on dibenzyl glycolic acid derivatives, which showcase an extraordinary anti-hypertensive and antisecretory profile.

Career Highlights

Vigelius has been associated with Warner-Lambert Company, where he has contributed to various innovative projects. His work has had a significant impact on the pharmaceutical industry, particularly in the development of therapeutic agents.

Collaborations

Throughout his career, Vigelius has collaborated with esteemed colleagues such as Gerhard Satzinger and Manfred F Herrmann. These partnerships have further enriched his research and development efforts.

Conclusion

Wolf-Dieter Vigelius stands out as a prominent inventor in the field of chemistry, with a focus on aminosulfonic acid derivatives. His contributions continue to influence medical therapies and showcase the importance of innovation in science.